A study by Konig-Greger et al47 showed that GSTM1-enzyme activity was significantly reduced in patients with head and neck carcinoma compared to controls, although it did not depend on the unfavorable GSTM1 genotype, which may suggest that other enzymes participate as regulators. Here, GSTM1 is linked to head and neck carcinoma.